TY - CHAP
T1 - Resilience Strategies and the Pharmaceutical Supply Chain
T2 - The Role of Agility in Mitigating Drug Shortages
AU - Vann Yaroson, Emilia
AU - Breen, Liz
AU - Hou, Jiachen
AU - Sowter, Julie
PY - 2019/6/2
Y1 - 2019/6/2
N2 - Supply chain resilience has been suggested to curb the impact of disruptions on supply chains. While this proposition seems coherent in theory, empirical evidence supporting this is limited, as existing literature has centred on exploring the impact of supply chain resilience on disruptions which are based on set time frames, non-supply chain specific as well as examining non-dynamic disruptive events. This study contends that resilience strategies are dynamic and as such their applications within supply chains differ. Therefore examining the impact of resilience will be appropriate on a dynamic disruption within a specific supply chain. In view of this, the paper examines through existing literature the applicability of agility within the pharmaceutical supply chain when dynamic disruptions like drug shortages occur. The study finds alertness, accessibility, connectivity and visibility as dimensions of supply chain agility that are capable of reducing the impact of drug shortages.
AB - Supply chain resilience has been suggested to curb the impact of disruptions on supply chains. While this proposition seems coherent in theory, empirical evidence supporting this is limited, as existing literature has centred on exploring the impact of supply chain resilience on disruptions which are based on set time frames, non-supply chain specific as well as examining non-dynamic disruptive events. This study contends that resilience strategies are dynamic and as such their applications within supply chains differ. Therefore examining the impact of resilience will be appropriate on a dynamic disruption within a specific supply chain. In view of this, the paper examines through existing literature the applicability of agility within the pharmaceutical supply chain when dynamic disruptions like drug shortages occur. The study finds alertness, accessibility, connectivity and visibility as dimensions of supply chain agility that are capable of reducing the impact of drug shortages.
KW - Resilience Strategies
KW - Pharmaceutical Supply Chain
KW - Drug Shortages
UR - http://www.scopus.com/inward/record.url?scp=85092576495&partnerID=8YFLogxK
UR - https://link.springer.com/book/10.1007/978-3-030-15398-4
UR - https://link.springer.com/chapter/10.1007/978-3-030-15398-4_19
U2 - 10.1007/978-3-030-15398-4_18
DO - 10.1007/978-3-030-15398-4_18
M3 - Chapter
SN - 9783030153977
SN - 9783030154004
T3 - Lecture Notes in Logistics
SP - 249
EP - 256
BT - Pharmaceutical Supply Chains - Medicine Shortages
A2 - Barbosa-Povoa, Ana Paula
A2 - Jenzer, Helena
A2 - Luís de Miranda, João
PB - Springer, Cham
ER -